In a new study published in the journal JCI Insight, researchers have identified the diabetes drug metformin as a potential treatment for atrial fibrillation (AFib).
AFib is a type of heart arrhythmia, or irregular heartbeat, that affects approximately 2.7 million adults in the United States alone. While treatment options are available, there is currently no cure for AFib.
In this study, researchers from the University of Michigan and the University of Texas Southwestern Medical Center collaborated to test the effects of metformin on a mouse model of AFib.
They found that metformin was able to significantly reduce the incidence of AFib in the mice. Additionally, metformin appeared to improve the function of the heart’s electrical system, which is often disrupted in people with AFib.
The results of this study suggest that metformin could be a potentially effective treatment for AFib in humans. However, further research is needed to confirm these findings.
If you or someone you love has AFib, talk to your doctor about the potential benefits of metformin and other treatment options.
In a recent study, researchers have found that the diabetes drug metformin may also help treat atrial fibrillation.
Atrial fibrillation is a condition that affects the heart’s rhythm and can lead to a number of health complications, including stroke. While there are treatments available to help manage atrial fibrillation, there is no cure.
The new study, which was a collaboration between researchers at the University of Birmingham and King’s College London, looked at the effect of metformin on atrial fibrillation in rats.
The results showed that metformin was able to significantly reduce the symptoms of atrial fibrillation and also improve the heart’s function.
While further research is needed to confirm these findings in humans, the results suggest that metformin may be a potential treatment for atrial fibrillation. This would be a significant advancement, as currently there are no therapies available that can cure atrial fibrillation.
The researchers hope that their findings will lead to clinical trials in humans in the near future. If metformin is found to be effective in treating atrial fibrillation, it could potentially help millions of people who suffer from this condition.
